Ascendis Pharma AS (ASND) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $228.99
• Market Cap: $13.99B
• EPS: $-4.43
• 52-Week High: $242.00
• 52-Week Low: $124.06

Market Sentiment

Ascendis Pharma AS currently has a Bullish sentiment score of 0.35.

About Ascendis Pharma AS

Ascendis Pharma A/S is a biopharmaceutical innovator based in Hellerup, Denmark, dedicated to creating transformative therapies for significant unmet medical needs in various therapeutic areas, particularly rare diseases and endocrine disorders. Leveraging its proprietary TransCon™ technology platform, the company is actively advancing a promising pipeline of product candidates through rigorous clinical trials. Ascendis is focused not only on developing groundbreaking treatments but also on e...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ascendis Pharma AS and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ASND pay dividends?

Ascendis Pharma AS (ASND) does not currently pay a regular dividend.

What is ASND's market cap?

Ascendis Pharma AS (ASND) has a market capitalization of $13.99B with a current stock price of $228.99.